Left atrial myxoma presenting as pulmonary embolism: Potential role of heme oxygenase-1

Blood Coagulation and Fibrinolysis

Volumn 25, Issue 6, 2014, Pages 621-624

  Redford, Daniel T ^a   Thompson, Jess L ^a   McCulloch, James C ^a   Nielsen, Vance G ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

atrial myxoma; carbon monoxide; heme oxygenase 1; pulmonary embolism; thrombelastography

Indexed keywords

CARBOXYHEMOGLOBIN; HEME OXYGENASE 1;

AGED; BLOOD; CASE REPORT; COMPLICATION; ENZYMOLOGY; GENETICS; HEART ATRIUM; HEART NEOPLASMS; HUMAN; MALE; METABOLISM; MYXOMA; PATHOLOGY; PULMONARY EMBOLISM; THROMBOELASTOGRAPHY; THROMBOPHILIA; UPREGULATION;

AGED; CARBOXYHEMOGLOBIN; HEART ATRIA; HEART NEOPLASMS; HEME OXYGENASE-1; HUMANS; MALE; MYXOMA; PULMONARY EMBOLISM; THROMBELASTOGRAPHY; THROMBOPHILIA; UP-REGULATION;

EID: 84905864427     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0000000000000097     Document Type: Article

References (13)

1. Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma: A series of 112 cases. Medicine 2001; 80: 159-172.
2. Garatti A, Nano G, Canziani A, Gagliardotto P, Mossuto E, Frigiola A, Menicanti L. Surgical excision of cardiac myxomas: Twenty years experience at a single institution. Ann Thorac Surg 2012; 93:825-831.
3. Zheng JJ, Geng XG, Wang HC, Yan Y, Wang HY. Clinical and histopathological analysis of 66 cases with cardiac myxoma. Asian Pacific J Cancer Prev 2013; 14:1742-1746.
4. Irani AD, Estrera AL, Buja LM, Safi HJ. Biatrail myxoma: A case report and review of the literature. J Card Surg 2008; 23:385-390.
5. Nagele R, Bonetti PO, Mayer KA. A patient with pulmonary embolism and a mass in the left atrium. Heart 2012; 98:1260.
6. Nielsen VG, Pearson T, Smith MC. Increased carbon monoxide production by hemeoxygenase-1 caused by device-mediated hemolysis: Thrombotic phantom menace?. Artif Organs 2013; 37:1008-1014.
7. Landaw SA, Callahan EW, Schmid R. Catabolism of heme in vivo: Comparison of the simultaneous production of bilirubin and carbon monoxide. J Clin Invest 1970; 49:914-925.
8. Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma. Blood Coagul Fibrinolysis 2009; 20:377-380.
9. Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 (CORM-2) decreases fibrinolysis in human plasma. Blood Coagul Fibrinolysis 2009; 20:448-455.
10. Nielsen VG, Garol BD, Zelman EA, Guerrero MA. Hemeoxygenase-1 mediated hypercoagulability in a patient with thyroid cancer. Blood Coagul Fibrinolysis 2013; 24:663-665.
11. Nielsen VG, Ley MLB, Waer AL, Alger PW, Matika RW, Steinbrenner EB. Plasmatic hypercoagulation in patients with breast cancer: Role of hemeoxygenase-1. Blood Coagul Fibrinolysis 2013; 24:809-813.
12. Nielsen VG, Hafner DT, Steinbrenner EB. Can divergent plasminantiplasmin- carbon monoxide interactions in young, healthy tobacco smokers explain the 'smoker's paradox'?. Blood Coagul Fibrinolysis 2013; 24:381-385.
13. Ellis TC, Nielsen VG, Marques MB, Kirklin JK. Thrombelastographic measures of clot propagation: A comparison of alpha to maximum rate of thrombus generation. Blood Coagul Fibrinolysis 2007; 18:45-48.